Compare Elder Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA FDC LTD. ELDER PHARMA/
FDC LTD.
 
P/E (TTM) x -0.2 17.4 - View Chart
P/BV x 0.1 2.6 3.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   FDC LTD.
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
FDC LTD.
Mar-18
ELDER PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs380319 119.1%   
Low Rs188164 114.6%   
Sales per share (Unadj.) Rs491.261.6 796.8%  
Earnings per share (Unadj.) Rs-3.29.9 -32.0%  
Cash flow per share (Unadj.) Rs14.412.0 120.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.573.2 514.6%  
Shares outstanding (eoy) m20.54174.40 11.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.63.9 14.8%   
Avg P/E ratio x-89.324.3 -367.7%  
P/CF ratio (eoy) x19.720.2 97.6%  
Price / Book Value ratio x0.83.3 22.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83342,118 13.9%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m2,1792,167 100.6%   
Avg. sales/employee Rs ThNM1,943.7-  
Avg. wages/employee Rs ThNM391.7-  
Avg. net profit/employee Rs ThNM313.7-  
INCOME DATA
Net Sales Rs m10,08910,751 93.8%  
Other income Rs m257510 50.4%   
Total revenues Rs m10,34611,260 91.9%   
Gross profit Rs m-7922,267 -34.9%  
Depreciation Rs m361351 102.8%   
Interest Rs m2,75614 19,687.9%   
Profit before tax Rs m-3,6532,411 -151.5%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125671 18.6%   
Profit after tax Rs m-651,735 -3.8%  
Gross profit margin %-7.821.1 -37.2%  
Effective tax rate %-3.427.8 -12.3%   
Net profit margin %-0.616.1 -4.0%  
BALANCE SHEET DATA
Current assets Rs m9,2407,213 128.1%   
Current liabilities Rs m9,9982,104 475.2%   
Net working cap to sales %-7.547.5 -15.8%  
Current ratio x0.93.4 27.0%  
Inventory Days Days4654 85.0%  
Debtors Days Days6028 216.2%  
Net fixed assets Rs m10,1246,865 147.5%   
Share capital Rs m206175 117.4%   
"Free" reserves Rs m5,58212,586 44.4%   
Net worth Rs m7,73412,761 60.6%   
Long term debt Rs m4,8896 81,483.3%   
Total assets Rs m22,88215,041 152.1%  
Interest coverage x-0.3173.2 -0.2%   
Debt to equity ratio x0.60 134,456.2%  
Sales to assets ratio x0.40.7 61.7%   
Return on assets %11.811.6 101.1%  
Return on equity %-0.813.6 -6.2%  
Return on capital %22.319.0 117.7%  
Exports to sales %3.012.3 24.6%   
Imports to sales %0.40-   
Exports (fob) Rs m3071,327 23.1%   
Imports (cif) Rs m43NA-   
Fx inflow Rs m3071,889 16.2%   
Fx outflow Rs m1250-   
Net fx Rs m1811,889 9.6%   
CASH FLOW
From Operations Rs m11,7541,498 784.4%  
From Investments Rs m-561201 -278.7%  
From Financial Activity Rs m-6,762-1,694 399.1%  
Net Cashflow Rs m4,43210 43,026.2%  

Share Holding

Indian Promoters % 39.6 68.9 57.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 4.7 159.6%  
FIIs % 16.8 7.5 224.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 19.0 190.0%  
Shareholders   16,479 23,730 69.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Up; Telecom Stocks Rally(09:30 am)

Asian share markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.6% while the Hang Seng is up 0.9%.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - ABBOTT INDIA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS